SCHEMBL13428141

SCHEMBL13428141

c1ccc(-c2c3cc(N4c5ccccc5CCc5ccccc54)ccc3c(-c3ccccc3-c3cccc4ccccc34)c3cc(N4c5ccccc5CCc5ccccc54)ccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP3A4 P08684 1/20 0.32
HTT P42858 1/20 0.32
LMNA P02545 3/20 0.31
RECQL P46063 1/20 0.31
HTR1A P08908 2/20 0.31
HTR7 P34969 2/20 0.31
SOS1 Q07889 1/20 0.30
ALDH1A1 P00352 2/20 0.30
HPGD P15428 2/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13008867 0.95 PDE6D (0.34) PDE6DPOLBKDM4ECYP1A2CYP2C9
SCHEMBL13008826 0.95 PDE6D (0.34) PDE6DPOLBKDM4ECYP1A2CYP2C9
SCHEMBL13428128 0.94 POLB (0.36) POLBKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL13428173 0.93 PDE6D (0.38) PDE6DPOLBKDM4ECYP1A2CYP2C9
SCHEMBL13009315 0.93 PDE6D (0.33) PDE6DPOLBKDM4ESOS1ALDH1A1
SCHEMBL13009190 0.93 POLB (0.35) POLBKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL13428147 0.92 PDE6D (0.36) PDE6DPOLBKDM4ECYP1A2CYP2C9
SCHEMBL13009022 0.91 PDE6D (0.33) PDE6DPOLBKDM4ECYP1A2CYP2C9
SCHEMBL13009377 0.90 PIM1 (0.35) POLBKDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL13428191 0.90 PDE6D (0.34) PDE6DPOLBKDM4ECYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
EP-2141214-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A PDE6D 3559/4885POLB 913/4885KDM4E 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.